SP-B and SP-C Containing New Synthetic Surfactant for Treatment of Extremely Immature Lamb Lung

被引:46
|
作者
Sato, Atsuyasu [1 ]
Ikegami, Machiko [1 ]
机构
[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA
来源
PLOS ONE | 2012年 / 7卷 / 07期
关键词
NATURAL SURFACTANT; PREMATURE LAMBS; PROTEIN; VENTILATION; PHOSPHATIDYLCHOLINE; EXPRESSION; ANALOGS;
D O I
10.1371/journal.pone.0039392
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although superiority of synthetic surfactant over animal-driven surfactant has been known, there is no synthetic surfactant commercially available at present. Many trials have been made to develop synthetic surfactant comparable in function to animal-driven surfactant. The efficacy of treatment with a new synthetic surfactant (CHF5633) containing dipalmitoylphosphatidylcholine, phosphatidylglycerol, SP-B analog, and SP-C analog was evaluated using immature newborn lamb model and compared with animal lung tissue-based surfactant Survanta. Lambs were treated with a clinical dose of 200 mg/kg CHF5633, 100 mg/kg Survanta, or air after 15 min initial ventilation. All the lambs treated with air died of respiratory distress within 90 min of age. During a 5 h study period, Pco(2) was maintained at 55 mmHg with 24 cmH(2)O peak inspiratory pressure for both groups. The preterm newborn lamb lung functions were dramatically improved by CHF5633 treatment. Slight, but significant superiority of CHF5633 over Survanta was demonstrated in tidal volume at 20 min and dynamic lung compliance at 20 and 300 min. The ultrastructure of CHF5633 was large with uniquely aggregated lipid particles. Increased uptake of CHF5633 by alveolar monocytes for catabolism was demonstrated by microphotograph, which might be associated with the higher treatment dose of CHF5633. The higher catabolism of CHF5633 was also suggested by the similar amount of surfactant lipid in bronchoalveolar lavage fluid (BALF) between CHF5633 and Survanta groups, despite the 2-fold higher treatment dose of CHF5633. Under the present ventilation protocol, lung inflammation was minimal for both groups, evaluated by inflammatory cell numbers in BALF and expression of IL-1 beta, IL-6, IL-8, and TNF alpha mRNA in the lung tissue. In conclusion, the new synthetic surfactant CHF5633 was effective in treating extremely immature newborn lambs with surfactant deficiency during the 5 h study period.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] SURFACTANT PROTEOLIPIDS SP-B AND SP-C
    WHITSETT, JA
    WEAVER, TE
    SURFACTANT AND THE RESPIRATORY TRACT, 1989, 12 : 67 - 74
  • [2] EFFECT OF PULMONARY SURFACTANT PROTEIN(SP)-A, SP-B, AND SP-C ON THE INVITRO SURFACTANT ACTIVITY - SP-B AND SP-C ACT COOPERATIVELY
    TAKAHASHI, A
    FUJIWARA, T
    SUZUKI, K
    PEDIATRIC RESEARCH, 1991, 29 (04) : A332 - A332
  • [3] Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs
    Rey-Santano, Carmen
    Mielgo, Victoria E.
    Murgia, Xabier
    Angel Gomez-Solaetxe, Miguel
    Salomone, Fabrizio
    Bianco, Federico
    Pelizzi, Nicola
    Loureiro, Begona
    Lopez de Heredia y Goya, Jon
    PEDIATRIC PULMONOLOGY, 2017, 52 (07) : 929 - 938
  • [4] Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C
    Ross, M
    Krol, S
    Janshoff, A
    Galla, HJ
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2002, 31 (01): : 52 - 61
  • [5] Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C
    Michaela Ross
    Silke Krol
    Andreas Janshoff
    Hans-Joachim Galla
    European Biophysics Journal, 2002, 31 : 52 - 61
  • [6] INTERACTION OF LIPID VESICLES WITH MONOMOLECULAR LAYERS CONTAINING LUNG SURFACTANT PROTEINS SP-B OR SP-C
    OOSTERLAKENDIJKSTERHUIS, MA
    HAAGSMAN, HP
    VANGOLDE, LMG
    DEMEL, RA
    BIOCHEMISTRY, 1991, 30 (33) : 8276 - 8281
  • [7] INHIBITION OF MIXTURES OF SURFACTANT LIPIDS AND SYNTHETIC SEQUENCES OF SURFACTANT PROTEINS SP-B AND SP-C
    AMIRKHANIAN, JD
    BRUNI, R
    WARING, AJ
    TAEUSCH, HW
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (04) : 355 - 360
  • [8] Evaluating Novel SP-B and SP-C Synthetic Analogues for Pulmonary Surfactant Efficacy
    Kim, Chae Young
    Chung, Sung-Hoon
    Choi, Yong Sung
    Park, Kyeong-Yong
    Bae, Chong-Woo
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (05): : 775 - 783
  • [9] IDENTITY AND BIOPHYSICAL ACTIVITY OF NATIVE AND SYNTHETIC SURFACTANT PROTEOLIPIDS SP-B AND SP-C
    OHNING, BL
    SARIN, V
    FOX, JL
    WHITSETT, JA
    PEDIATRIC RESEARCH, 1989, 25 (04) : A322 - A322
  • [10] Effects of surfactant proteins SP-B and SP-C on dynamic and static mechanics of immature lungs
    Kobayashi, T
    Tashiro, K
    Yamamoto, K
    Nitta, S
    Ohmura, S
    Suzuki, Y
    JOURNAL OF APPLIED PHYSIOLOGY, 1997, 83 (06) : 1849 - 1856